These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11532312)

  • 1. Cross-linked high amylose starch derivatives as matrices for controlled release of high drug loadings.
    Mulhbacher J; Ispas-Szabo P; Lenaerts V; Mateescu MA
    J Control Release; 2001 Sep; 76(1-2):51-8. PubMed ID: 11532312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
    Mulhbacher J; Ispas-Szabo P; Mateescu MA
    Int J Pharm; 2004 Jul; 278(2):231-8. PubMed ID: 15196628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linked high amylose starch derivatives for drug release III. Diffusion properties.
    Mulhbacher J; Mateescu MA
    Int J Pharm; 2005 Jun; 297(1-2):22-9. PubMed ID: 15878244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive properties of cross-linked high amylose starch derivatives.
    Mulhbacher J; Ispas-Szabo P; Ouellet M; Alex S; Mateescu MA
    Int J Biol Macromol; 2006 Dec; 40(1):9-14. PubMed ID: 16837041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ampholytic starch excipients for high loaded drug formulations: Mechanistic insights.
    Sakeer K; Ispas-Szabo P; Benyerbah N; Mateescu MA
    Int J Pharm; 2018 Jan; 535(1-2):201-216. PubMed ID: 29128422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Stabilizing Ampholytic Starch Excipients for Sustained Release of Highly Soluble Drugs: the Case Study of Metformin.
    Sakeer K; Ispas-Szabo P; Mateescu MA
    AAPS PharmSciTech; 2017 Oct; 18(7):2658-2672. PubMed ID: 28271374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spray-dried high-amylose sodium carboxymethyl starch: impact of α-amylase on drug-release profile.
    Nabais T; Zaraa S; Leclair G
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1887-93. PubMed ID: 27109692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxymethyl Starch Excipients for Drug Chronodelivery.
    Ispas-Szabo P; De Koninck P; Calinescu C; Mateescu MA
    AAPS PharmSciTech; 2017 Jul; 18(5):1673-1682. PubMed ID: 27686941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of drying procedure and of low degree of substitution on the structural and drug release properties of carboxymethyl starch.
    Lemieux M; Gosselin P; Mateescu MA
    AAPS PharmSciTech; 2010 Jun; 11(2):775-85. PubMed ID: 20443088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
    Lemieux M; Gosselin P; Mateescu MA
    Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified high amylose starch for immobilization of uricase for therapeutic application.
    Mulhbacher J; McGeeney K; Ispas-Szabo P; Lenaerts V; Mateescu MA
    Biotechnol Appl Biochem; 2002 Dec; 36(3):163-70. PubMed ID: 12452799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-linked high amylose starch for controlled release of drugs: recent advances.
    Lenaerts V; Moussa I; Dumoulin Y; Mebsout F; Chouinard F; Szabo P; Mateescu MA; Cartilier L; Marchessault R
    J Control Release; 1998 Apr; 53(1-3):225-34. PubMed ID: 9741930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery.
    Calinescu C; Mateescu MA
    Eur J Pharm Biopharm; 2008 Oct; 70(2):582-9. PubMed ID: 18602991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of protonation ratio on properties of carboxymethyl starch excipient at various substitution degrees: Structural insights and drug release kinetics.
    Assaad E; Mateescu MA
    Int J Pharm; 2010 Jul; 394(1-2):75-84. PubMed ID: 20435114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of some physical parameters on the sustained drug-release properties of substituted amylose matrices.
    Chebli C; Cartilier L
    Int J Pharm; 2000 Jan; 193(2):167-73. PubMed ID: 10606779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Preflo modified starches as new direct compression excipients. I. Tabletting characteristics.
    Sanghvi PP; Collins CC; Shukla AJ
    Pharm Res; 1993 Nov; 10(11):1597-603. PubMed ID: 8290472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylated high amylose starch as pharmaceutical excipients. Structural insights and formulation of pancreatic enzymes.
    Massicotte LP; Baille WE; Mateescu MA
    Int J Pharm; 2008 May; 356(1-2):212-23. PubMed ID: 18403141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.